UnitedHealth Group Incorporated (UNH)
| Market Cap | 299.65B |
| Revenue (ttm) | 435.16B |
| Net Income (ttm) | 17.59B |
| Shares Out | 905.84M |
| EPS (ttm) | 19.22 |
| PE Ratio | 17.21 |
| Forward PE | 19.72 |
| Dividend | $8.84 (2.67%) |
| Ex-Dividend Date | Dec 8, 2025 |
| Volume | 3,607,583 |
| Open | 335.00 |
| Previous Close | 333.49 |
| Day's Range | 328.51 - 335.71 |
| 52-Week Range | 234.60 - 608.99 |
| Beta | 0.43 |
| Analysts | Buy |
| Price Target | 407.88 (+23.3%) |
| Earnings Date | Jan 15, 2026 |
About UNH
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older; Medicaid plans, children’s health insurance and health... [Read more]
Financial Performance
In 2024, UnitedHealth Group's revenue was $400.28 billion, an increase of 7.71% compared to the previous year's $371.62 billion. Earnings were $14.41 billion, a decrease of -35.64%.
Financial StatementsAnalyst Summary
According to 25 analysts, the average rating for UNH stock is "Buy." The 12-month stock price target is $407.88, which is an increase of 23.30% from the latest price.
News
UNH Stock In 2026: Bull And Bear Case Scenarios
For UnitedHealth's stock, the Medical Care Ratio (MCR) serves as the most significant factor influencing core profitability. The unexpected rise in MCR from around 82% in 2022 to an anticipated 88% in...
UnitedHealth: Time To Buy This Healthcare Fortress
UnitedHealth Group is rated Buy, with the worst seemingly behind and a clear path to margin recovery and earnings growth from 2026 onward. UNH's 2025 headwinds - higher medical expense ratio, Medicare...
Why UnitedHealth Stock Popped on Wednesday
An analyst raised his price target on the health insurer by 14%. He also kept his buy recommendation intact.
Up 37% Since August, Is It Safe to Buy UnitedHealth Group Stock Again?
UnitedHealth has been facing multiple headwinds recently, including rising costs and increasing utilization rates. The company has been growing, and last quarter, it raised its guidance.
UnitedHealth Stock Analysis: Buy or Sell?
UnitedHealth (UNH +0.60%) stock is testing the patience of investors.
Is UnitedHealth an Undervalued Stock to Buy Now?
UnitedHealth Group is navigating soaring costs and a volatile political landscape. The company is raising its premiums to address its collapsing margins.
UnitedHealth: Axing Another Distraction, Onto 2026
UnitedHealth Group Incorporated is positioned for a multi-year turnaround, with 2026 marking the inflection and 2027 expected to deliver significant margin expansion. UNH's exit from Latin America, in...
Mangione shown videos of UnitedHealthcare CEO killing in court
Luigi Mangione has watched surveillance videos of the killing of UnitedHealthcare CEO Brian Thompson at a court appearance.
UnitedHealth agrees to sell South American business to private equity firm Patria for $1 billion, sources say
UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria Investments for $1 billion, two sources with knowledge of the matter said on S...
American Century Ultra Fund Q3 2025 Contributors/Detractors And Notable Trades
Google's parent company received a relatively benign antitrust ruling that would not force Alphabet to sell its Chrome browser or Android operating system. Chipotle Mexican Grill reported mixed quarte...
Why Billionaire David Tepper Just Sold 92% of UnitedHealth Group and Is Buying These 3 Stocks Instead
Tepper slashed his hedge fund's position in UnitedHealth Group, perhaps to take some profits off the table. He loaded up on Whirlpool, Qualcomm, and AMD stocks.
Smart Meter Opinion Editorial: Remote Patient Monitoring Works. UnitedHealthcare's 2026 Rollback Ignores the Evidence, and Patients Will Pay the Price.
TAMPA, Fla.--(BUSINESS WIRE)--The following is an opinion editorial provided by Casey Pittock, CEO, Smart Meter: UnitedHealthcare's decision to sharply limit remote patient monitoring (RPM) reimbursem...
Health Insurer Stocks Rise On Reports Obamacare Subsidies To Be Extended
Health insurance company stocks jumped Monday on news the Donald Trump White House and Republicans in Congress will float an extension of tax credits for those with low and moderate incomes so they ca...
Should You Buy Shares of UnitedHealth in November?
UnitedHealth stock has tumbled 35% this year amid a series of headwinds. The company has addressed certain challenges in recent months, and efforts are starting to bear fruit.
Why Did UNH Stock Lose Half Its Value And What Comes Next?
UnitedHealth's stock plummeted from over $600 to approximately $310-$320 (nearly 50% down) over the last year, and it's not merely market fluctuations. This decline stems from a significant issue cent...
Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent
Ubisoft Entertainment (OTCPK:UBSFY) surged nearly 9% after Tencent invested €1.16B in its Vantage Studios, boosting transformation and reducing debt. Tencent (OTCPK:TCEHY) now holds a 26.32% economic ...
UnitedHealth: Buy Before The Buybacks Resume
While the market fixates on UnitedHealth's buyback pause as a sign of distress, a granular analysis of the balance sheet reveals a highly calculable, yet overlooked, path to deleveraging. Investors ar...
UnitedHealth is dropping a million seniors from Medicare Advantage as it aims to restore its ‘swagger'
America's largest insurer is making sweeping changes to its Medicare Advantage plans to improve profit margins.
4 No-Brainer Dividend Stocks to Buy Right Now -- and a 17% Dividend Yield to Avoid
Any long-term investor seeking income, and growing income at that, should take a closer look at these suggestions. Several are in the portfolio of Warren Buffett's company, Berkshire Hathaway.
UnitedHealth Group Taps Former FDA Chief And Medicare Advisor To Board
UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.
What Could Ignite UNH Stock's Next Major Rally?
UnitedHealth stock (NYSE: UNH) has faced significant pressure this year, creating a potential setup for a major rally.
Former FDA commissioner Scott Gottlieb joins UnitedHealth board
UnitedHealth Group said on Tuesday former U.S. Food and Drug Administration commissioner Scott Gottlieb has joined the company's board of directors.
Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors
--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group's (NYSE: UNH) Board of Directors, effective immediately. Dr. Gottlieb,...
Prediction: 1 Dirt Cheap Warren Buffett Stock That Will Be Worth More Than Palantir By 2030
Palantir's valuation is far above what investors witnessed at the peak of the dot-com bubble. UnitedHealth stock sold off earlier this year amid some operational headwinds.